Sodium zirconium cyclosilicate, known by the brand name Lokelma, is a tablet that reduces potassium levels in the body.
Here's a breakdown:
- Mechanism of Action: According to the Medscape Reference, sodium zirconium cyclosilicate works by preferentially capturing potassium in the gastrointestinal (GI) tract.
- Process: This tablet exchanges potassium for hydrogen and sodium.
- Result: This process reduces the amount of free potassium in the GI tract's lumen, which in turn lowers the serum potassium level in the blood.
- FDA Approval: Sodium zirconium cyclosilicate (Lokelma) is FDA-approved for treating hyperkalemia (high potassium) in adults.
In summary, sodium zirconium cyclosilicate (Lokelma) is the tablet that is explicitly mentioned in the provided reference as reducing potassium levels.
